Changes in alpha-1 and beta-2 adrenoceptor density in human hepatocellular carcinoma
β Scribed by Maurizio Bevilacqua; Guido Norbiato; Enrica Chebat; Gabriella Baldi; Pierluigi Bertora; Tarcisio Vago; Enrico Regalia; Giovanni Colella; Leandro Gennari
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 753 KB
- Volume
- 67
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Catecholamines are involved critically in the mechanisms of liver cell proliferation by acting on hepatic alpha-1 and beta-2 adrenoceptors. To identify the role of these receptors in human hepatocellular carcinoma (HCC), the density was examined of alpha-1 and beta-2 adrenoceptors with their affinity and coupling of beta-2 adrenoceptors to adenylate cyclase in HCC tissue and in nonadjacent/nontumor tissue from the same livers. Studies were also done on healthy livers from agematched and sex-matched patients undergoing abdominal surgery for nonhepatic diseases. Twenty-two HCC had a decrease of about 72% in alpha-1 adrenoceptor density compared with their nonadjacent/nontumor tissue and a decrease of about 40% compared with healthy controls. Nonadjacent/nontumor tissue from HCC patients had a 125% increase in alpha-1 adrenoceptor density compared with healthy livers. Twenty-three of 24 HCC had an increase of about 180% in beta adrenoceptor density compared with their nonadjacent/nontumor tissue and healthy controls. Beta adrenoceptors were coupled to adenylate cyclase, as evidenced by a guanosine triphosphate-mediated right shift in (-)-isoproterenol competition isotherms and by cyclic adenosine monophosphate (CAMP) production after stimulation with (-)-isoproterenol. The HCC tissue yielded a larger increase in CAMP than nonadjacent/nontumor tissue and healthy controls. The authors conclude that a higher density of alpha-1 adrenoceptors in nonadjacent/nontumor tissue from HCC characterizes the "healthy" part of the liver in HCC patients and that an increase in beta-2 and a decrease in alpha-1 adrenoceptor densities characterize the tumor part of the liver in human HCC. Cancer 67:2543-2551,1991. N ADULT HUMANS and animals, hepatocytes have long I life spans, ranging from 200 to 400 days or more, but it is a common observation that the proliferation rate of hepatocytes increases after hepatic cell death or loss of liver tissue.' Hepatocyte proliferation occurs in viral hepatitis, cirrhosis, hepatotoxic reactions, and massive liver necrosis.* In turn, viral hepatitis and cirrhosis are strongly associated with hepatocellular carcinoma (HCC), a usually
π SIMILAR VOLUMES
## Abstract Alphaβfetoprotein and variant alkaline phosphatase were studied in a group of patients with hepatoma. The incidence of positive alphaβfetoprotein was 67.6% in confirmed cases. Variant alkaline phosphatase was present only in patients with positive fetoprotein test, and it appeared in on
miR-122 is a highly abundant, hepatocyte-specific microRNA. The biomedical significance and regulatory mechanisms of miR-122 remain obscure. We explored the role of miR-122 in tumorigenesis in the context of gene regulatory network. The miR-122 promoter and its transactivator were identified by way
## BACKGROUND. Telomeres, at the ends of eukaryotic chromosomes, are defined functionally as necessary for chromosome stability. Chromosome instability induced in part by loss of telomeric DNA has been considered to play a significant role in the development of human cancers. However, little is kn
We read with great interest the article by Teixera-Clerc et al., 1 regarding the hepatoprotective properties displayed by cannabinoid receptor 2 (CB2) agonists in a mouse model of carbon tetrachloride (CCl 4 )-induced liver injury. Acute hepatitis induced by CCl 4 was accelerated in CB2 knockout mic